Quantification of inflammatory cytokines in exhaled breath particles following segmental and inhalation endotoxin challenge of healthy volunteers Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021
Salmeterol pharmacokinetics following a 50-mcg dose by dry powder oral inhalation to healthy volunteers Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012
Inhaled LPS challenge in healthy subjects: a dose escalation study Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
Diverging airway inflammatory responses to diesel exhaust exposure in healthy and asthmatic subjects with and without inhaled corticosteroid treatment Source: Eur Respir J 2002; 20: Suppl. 38, 22s Year: 2002
Comparison of systemic bioavailability of two formulations of budesonide nebulized suspension in healthy subjects Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009
Pulmonary pharmacokinetics and safety of nebulised duramycin in healthy male volunteers Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009
Tolerability and pharmacokinetics of inhaled bimosiamose in healthy human volunteers Source: Eur Respir J 2006; 28: Suppl. 50, 332s Year: 2006
The safety and feasibility of the inhaled mannitol challenge test in young children Source: Eur Respir J 2013; 42: 1420-1423 Year: 2013
Airway responsiveness in healthy subjects following exposure to ammonia Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Dose escalation study in healthy male subjects to investigate safety, tolerability and systemic exposure of orally inhaled single-doses of AP301 Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
Salmeterol has no effect on increased bronchial responsiveness induced by organic dust exposure in healthy volunteers Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Bronchodilator response in healthy subjects Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020
Safety and tolerability of single doses of AZD5069 in healthy volunteers Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Assessment of usability of a novel multi-dose dry powder inhaler in healthy volunteers and mild asthmatics Source: Eur Respir J 2007; 30: Suppl. 51, 70s Year: 2007
Dry powder inhaled ribavirin in healthy volunteers: safety, tolerability, lung and systemic pharmacokinetics Source: International Congress 2017 – From microbiology to clinical work Year: 2017
Comparison of pulmonary and systemic absoption of two HFA formulations of salmeterol in healthy subjects Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
The anti-IL-17A-antibody secukinumab does not attenuate ozone induced acute airway neutrophilia in healthy volunteers Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012
Respiratory effects in a chamber study of diesel exhaust exposure in healthy volunteers Source: Annual Congress 2012 - Air pollution: from the particles in town to the pollutants in the countryside Year: 2012
Comparison of breathing acoustic characteristics in patients with asthma and healthy volunteers Source: Eur Respir J 2005; 26: Suppl. 49, 118s Year: 2005
Comparison of aerosol deposition pattern in healthy vs. asthmatic subjects Source: Annual Congress 2012 - Different ways to phenotype asthma Year: 2012